Completing data — refresh the page later to see the latest
6639-79-8O=c1[nH]c2ccc(Cl)cc2[nH]c1=ORNOLFZACEWWIHP-UHFFFAOYSA-Nstructure given in first source; competative antagonist highly selective to the strychnine-insensitive Gly binding sites within the NMDA receptor complex
6639-79-8DTXSID8064436Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Warning
H302 (16.7%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 6 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Uses6-Chloroquinoxaline-2,3-diol can be used as glycine receptor antagonists to use as analgesics, anticonvulsants, neuroprotectants, and sedative-hypnotics.
CHEMBL21641